[Prevention of avoidable iatrogenic disease: when patient safety joins with health care economics].
The prevention of preventable adverse therapeutic events (iatrogenic), especially drug related, is a major medical goal for patients, economics and the community. Its incidence is 5 to 15 per cent of hospitalization days. Preventable iatrogenic is a main problem in terms of public health owing to its human and economic consequences. Prevention of iatrogenic is based on better knowledge of its reality, on well-adapted initial and long-term intensive training of physicians, other healthcare workers and also patients and citizens. A better healthcare system is also needed.
Queneau
P
P
Service de Médecine Interne et de Thérapeutique, Hôpital Bellevue, CHU de Saint-Etienne, 42055 Saint-Etienne, France.
Bergmann
J F
JF
D003695:Delivery of Health Care / Q000592:standards; D064420:Drug-Related Side Effects and Adverse Reactions; D005602:France / Q000453:epidemiology; D006801:Humans; D007049:Iatrogenic Disease / Q000453:epidemiology / Q000517:prevention & control*; D015994:Incidence; D007902:Length of Stay; D019300:Medical Errors / Q000706:statistics & numerical data; D011785:Quality Assurance, Health Care; D012449:Safety